BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25626130)

  • 1. Effect of oxidized low-density lipoprotein on the expression of the prorenin receptor in human aortic smooth muscle cells.
    Cheng Y; Liu X; Zhang L; Zhang Y; Liu Y; Lu Y; Jiang Y
    Mol Med Rep; 2015 Jun; 11(6):4341-4. PubMed ID: 25626130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.
    Yisireyili M; Saito S; Abudureyimu S; Adelibieke Y; Ng HY; Nishijima F; Takeshita K; Murohara T; Niwa T
    PLoS One; 2014; 9(10):e109268. PubMed ID: 25343458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic effect of prorenin on human aortic smooth muscle cells: a novel function of the (pro)renin receptor.
    Greco CM; Camera M; Facchinetti L; Brambilla M; Pellegrino S; Gelmi ML; Tremoli E; Corsini A; Ferri N
    Cardiovasc Res; 2012 Aug; 95(3):366-74. PubMed ID: 22721990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells.
    Ferri N; Greco CM; Maiocchi G; Corsini A
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):469-74. PubMed ID: 21628356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells.
    Viola M; Bartolini B; Vigetti D; Karousou E; Moretto P; Deleonibus S; Sawamura T; Wight TN; Hascall VC; De Luca G; Passi A
    J Biol Chem; 2013 Oct; 288(41):29595-603. PubMed ID: 23979132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
    Chen KC; Wang YS; Hu CY; Chang WC; Liao YC; Dai CY; Juo SH
    FASEB J; 2011 May; 25(5):1718-28. PubMed ID: 21266537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells.
    Sukhanov S; Hua Song Y; Delafontaine P
    Biochem Biophys Res Commun; 2003 Jun; 306(2):443-9. PubMed ID: 12804583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin inhibits proliferation and promotes apoptosis of vascular smooth muscle cells by regulating the MEG3/p53 pathway following treatment with ox‑LDL.
    Liu Y; Jia L; Min D; Xu Y; Zhu J; Sun Z
    Int J Mol Med; 2019 Feb; 43(2):901-913. PubMed ID: 30535498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
    Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
    J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors.
    Lin SJ; Shyue SK; Shih MC; Chu TH; Chen YH; Ku HH; Chen JW; Tam KB; Chen YL
    Atherosclerosis; 2007 Jan; 190(1):124-34. PubMed ID: 16600249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetazidine Protects Against Atherosclerosis by Changing Energy Charge and Oxidative Stress.
    Zheng S; Du Y; Peng Q; Fan X; Li J; Chen M
    Med Sci Monit; 2018 Nov; 24():8459-8468. PubMed ID: 30468686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells.
    Sukhanov S; Delafontaine P
    Proteomics; 2005 Apr; 5(5):1274-80. PubMed ID: 15732133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin.
    Liu J; Ren Y; Kang L; Zhang L
    Int J Mol Med; 2014 May; 33(5):1341-7. PubMed ID: 24590381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor.
    Higashi Y; Peng T; Du J; Sukhanov S; Li Y; Itabe H; Parthasarathy S; Delafontaine P
    J Lipid Res; 2005 Jun; 46(6):1266-77. PubMed ID: 15805544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-Renin Receptor Overexpression Promotes Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice.
    Ma H; Dong XF; Cao XR; Hei NH; Li JL; Wang YL; Kong J; Dong B
    Hum Gene Ther; 2020 Jun; 31(11-12):639-650. PubMed ID: 31992084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.
    Huang J; Siragy HM
    Endocrinology; 2009 Dec; 150(12):5557-65. PubMed ID: 19861503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells.
    Gonzalez AA; Luffman C; Bourgeois CR; Vio CP; Prieto MC
    Hypertension; 2013 Feb; 61(2):443-9. PubMed ID: 23184385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.